Christopher A. Baratta
Lawyers
Filters
Terns Pharmaceuticals $747.5 million common stock offering
We advised the underwriters on the public offering
Immix Biopharma $100 million stock and pre-funded warrants offering
We advised the sole bookrunner and representative of the several underwriters on the offering
Immatics $125 million follow-on offering
We advised Immatics on the offering
Aveanna $90 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Applied Materials $1 billion senior notes offering
The investment-grade notes are due 2031 and 2036
Cardinal Health $1 billion notes offering
The investment-grade notes are due 2030 and 2035
Eli Lilly $6.75 billion notes offering
The investment-grade offering consisted of seven tranches
Travel + Leisure $500 million senior secured notes offering
The high-yield notes are due 2033
Hinge Health $503 million IPO
The shares are listed on the New York Stock Exchange
ACELYRIN $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market